rs4784675

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_031885.5(BBS2):​c.613-54C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.155 in 1,352,452 control chromosomes in the GnomAD database, including 17,360 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.16 ( 2232 hom., cov: 32)
Exomes 𝑓: 0.15 ( 15128 hom. )

Consequence

BBS2
NM_031885.5 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 0.122

Publications

10 publications found
Variant links:
Genes affected
BBS2 (HGNC:967): (Bardet-Biedl syndrome 2) This gene is a member of the Bardet-Biedl syndrome (BBS) gene family. Bardet-Biedl syndrome is an autosomal recessive disorder characterized by severe pigmentary retinopathy, obesity, polydactyly, renal malformation and cognitive disability. The proteins encoded by BBS gene family members are structurally diverse and the similar phenotypes exhibited by mutations in BBS gene family members is likely due to their shared roles in cilia formation and function. Many BBS proteins localize to the basal bodies, ciliary axonemes, and pericentriolar regions of cells. BBS proteins may also be involved in intracellular trafficking via microtubule-related transport. The protein encoded by this gene forms a multiprotein BBSome complex with seven other BBS proteins.[provided by RefSeq, Oct 2014]
BBS2 Gene-Disease associations (from GenCC):
  • Bardet-Biedl syndrome 2
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae), Myriad Women’s Health
  • ciliopathy
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • retinitis pigmentosa 74
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • retinitis pigmentosa
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Bardet-Biedl syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 16-56506278-G-C is Benign according to our data. Variant chr16-56506278-G-C is described in ClinVar as Benign. ClinVar VariationId is 1172737.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.214 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
BBS2NM_031885.5 linkc.613-54C>G intron_variant Intron 5 of 16 ENST00000245157.11 NP_114091.4 Q9BXC9

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
BBS2ENST00000245157.11 linkc.613-54C>G intron_variant Intron 5 of 16 1 NM_031885.5 ENSP00000245157.5 Q9BXC9

Frequencies

GnomAD3 genomes
AF:
0.164
AC:
24911
AN:
151968
Hom.:
2229
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.208
Gnomad AMI
AF:
0.120
Gnomad AMR
AF:
0.124
Gnomad ASJ
AF:
0.0655
Gnomad EAS
AF:
0.225
Gnomad SAS
AF:
0.220
Gnomad FIN
AF:
0.138
Gnomad MID
AF:
0.114
Gnomad NFE
AF:
0.148
Gnomad OTH
AF:
0.160
GnomAD4 exome
AF:
0.154
AC:
185073
AN:
1200366
Hom.:
15128
AF XY:
0.156
AC XY:
95098
AN XY:
609318
show subpopulations
African (AFR)
AF:
0.214
AC:
5977
AN:
27958
American (AMR)
AF:
0.126
AC:
5485
AN:
43560
Ashkenazi Jewish (ASJ)
AF:
0.0725
AC:
1779
AN:
24542
East Asian (EAS)
AF:
0.200
AC:
7480
AN:
37470
South Asian (SAS)
AF:
0.211
AC:
16857
AN:
80036
European-Finnish (FIN)
AF:
0.136
AC:
6750
AN:
49510
Middle Eastern (MID)
AF:
0.154
AC:
809
AN:
5256
European-Non Finnish (NFE)
AF:
0.150
AC:
131852
AN:
880304
Other (OTH)
AF:
0.156
AC:
8084
AN:
51730
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
8340
16680
25021
33361
41701
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4352
8704
13056
17408
21760
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.164
AC:
24939
AN:
152086
Hom.:
2232
Cov.:
32
AF XY:
0.163
AC XY:
12113
AN XY:
74362
show subpopulations
African (AFR)
AF:
0.207
AC:
8601
AN:
41456
American (AMR)
AF:
0.124
AC:
1895
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.0655
AC:
227
AN:
3468
East Asian (EAS)
AF:
0.224
AC:
1161
AN:
5174
South Asian (SAS)
AF:
0.218
AC:
1052
AN:
4820
European-Finnish (FIN)
AF:
0.138
AC:
1464
AN:
10582
Middle Eastern (MID)
AF:
0.122
AC:
36
AN:
294
European-Non Finnish (NFE)
AF:
0.148
AC:
10048
AN:
67974
Other (OTH)
AF:
0.164
AC:
346
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1055
2110
3164
4219
5274
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
282
564
846
1128
1410
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.155
Hom.:
236
Bravo
AF:
0.164
Asia WGS
AF:
0.252
AC:
874
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
May 10, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Retinitis pigmentosa 74 Benign:1
Jun 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Bardet-Biedl syndrome 2 Benign:1
Jun 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
CADD
Benign
5.5
DANN
Benign
0.50
PhyloP100
0.12
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4784675; hg19: chr16-56540190; COSMIC: COSV104392583; API